🇺🇸 FDA
Patent

US 7666886

Compounds and methods for the diagnosis and treatment of amyloid associated diseases

granted A61PA61P25/16A61P25/28

Quick answer

US patent 7666886 (Compounds and methods for the diagnosis and treatment of amyloid associated diseases) held by The Regents of the University of California expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P25/16, A61P25/28